Advanced search
Publication Cover
Future Virology Volume 2, 2007 - Issue 1
Submit an article Journal homepage
108
Views
0
CrossRef citations to date
0
Altmetric
Review

Reverse Transcription Complex: The Key Player of the Early Phase of HIV Replication

Sergey N IordanskiyThe George Washington University,Department of Microbiology,Immunology & Tropical Medicine,2300 I Street North West,Washington,DC20037,USA and The D.I. Ivanovsky Institute of Virology,Department of Molecular Virology,16 Gamaleya Street,Moscow123098,Russia Tel.: +1 202 994 2146; Fax.: +1 202 994 2913; [email protected]View further author information
&
Michael I BukrinskyCorrespondence[email protected]
View further author information
Pages 49-64 | Published online: 20 Dec 2006

Bibliography

  • Bukrinsky MI , SharovaN, McDonaldTL, PushkarskayaT, TarpleyWG, StevensonM: Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.Proc. Natl Acad. Sci. USA90, 6125–6129 (1993).
  • Miller MD , FarnetCM, BushmanFD: Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.J. Virol.71, 5382–5390 (1997).
  • Lin CW , EngelmanA: The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes.J. Virol.77, 5030–5036 (2003).
  • Llano M , VanegasM, FregosoOet al.: LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes.J. Virol.78, 9524–9537 (2004).
  • Weinberg JB , MatthewsTJ, CullenBR, MalimMH: Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes.J. Exp. Med.174, 1477–1482 (1991).
  • Bukrinsky MI , SharovaN, DempseyMPet al.: Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.Proc. Natl Acad. Sci. USA89, 6580–6584 (1992).
  • Lehmann-Che J , GironML, DelelisOet al.: Protease-dependent uncoating of a complex retrovirus.J. Virol.79, 9244–9253 (2005).
  • Lewis P , HenselM, EmermanM: Human immunodeficiency virus infection of cells arrested in the cell cycle.EMBO J.11, 3053–3058 (1992).
  • Roe T , ReynoldsTC, YuG, BrownPO: Integration of murine leukemia virus DNA depends on mitosis.EMBO J.12, 2099–2108 (1993).
  • Nisole S , SaibA: Early steps of retrovirus replicative cycle.RetroVirology1, 9 (2004).
  • Pornillos O , GarrusJE, SundquistWI: Mechanisms of enveloped RNA virus budding.Trends Cell Biol.12, 569–579 (2002).
  • Haffar O , BukrinskyM: Nuclear translocation as a novel target for anti-HIV drugs.Expert Rev. Anti Infect. Ther.3, 41–50 (2005).
  • Goff SP : Retrovirus restriction factors.Mol. Cell16, 849–859 (2004).
  • Romano G : Current development of lentiviral-mediated gene transfer.Drug News Perspect.18, 128–134 (2005).
  • Farnet CM , HaseltineWA: Integration of human immunodeficiency virus type 1 DNA in vitro.Proc. Natl Acad. Sci. USA87, 4164–4168 (1990).
  • Dvorin JD , MalimMH: Intracellular trafficking of HIV-1 cores: journey to the center of the cell.Curr. Top. Microbiol. Immunol.281, 179–208 (2003).
  • Khan M , Garcia-BarrioM, PowellMD: Treatment of human immunodeficiency virus type 1 virions depleted of cyclophilin a by natural endogenous reverse transcription restores infectivity.J. Virol.77, 4431–4434 (2003).
  • Trono D : Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.J. Virol.66, 4893–4900 (1992).
  • Zhang H , DornadulaG, OrensteinJ, PomerantzRJ: Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.J. Hum. Virol.3, 165–172 (2000).
  • Campbell EM , NunezR, HopeTJ: Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.J. Virol.78, 5745–5755 (2004).
  • Bukrinskaya A , BrichacekB, MannA, StevensonM: Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.J. Exp. Med.188, 2113–2125 (1998).
  • Hottiger M , GramatikoffK, GeorgievO, ChaponnierC, SchaffnerW, HubscherU: The large subunit of HIV-1 reverse transcriptase interacts with β-actin.Nucleic Acids Res.23, 736–741 (1995).
  • Pal R , ReitzMSJr, TschachlerE, GalloRC, SarngadharanMG, VeroneseFD: Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.AIDS Res. Hum. Retroviruses6, 721–730 (1990).
  • Bukrinskaya AG , GhorpadeA, HeinzingerNK, SmithgallTE, LewisRE, StevensonM: Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.Proc. Natl Acad. Sci. USA93, 367–371 (1996).
  • Jacque JM , MannA, EnslenHet al.: Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.EMBO J.17, 2607–2618 (1998).
  • Kaushik R , RatnerL: Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication.J. Virol.78, 2319–2326 (2004).
  • Konvalinka J , HeuserAM, Hruskova-HeidingsfeldovaOet al.: Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases.Eur. J. Biochem.228, 191–198 (1995).
  • Krausslich HG , FackeM, HeuserAM, KonvalinkaJ, ZentgrafH: The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.J. Virol.69, 3407–3419 (1995).
  • Kotov A , ZhouJ, FlickerP, AikenC: Association of nef with the human immunodeficiency virus type 1 core.J. Virol.73, 8824–8830 (1999).
  • Kaplan AH , SwanstromR: Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.Proc. Natl Acad. Sci. USA88, 4528–4532 (1991).
  • Ganser BK , LiS, KlishkoVY, FinchJT, SundquistWI: Assembly and analysis of conical models for the HIV-1 core.Science283, 80–83 (1999).
  • Iordanskiy S , BerroR, AltieriM, KashanchiF, BukrinskyM: Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin.RetroVirology3, 4 (2006).
  • Dismuke DJ , AikenC: Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex.J. Virol.80, 3712–3720 (2006).
  • McDonald D , VodickaMA, LuceroGet al.: Visualization of the intracellular behavior of HIV in living cells.J. Cell Biol.159, 441–452 (2002).
  • Grewe C , BeckA, GelderblomHR: HIV: early virus-cell interactions.J. Acquir. Immune Defic. Syndr.3, 965–974 (1990).
  • Bowerman B , BrownPO, BishopJM, VarmusHE: A nucleoprotein complex mediates the integration of retroviral DNA.Genes Dev.3, 469–478 (1989).
  • Li S , HillCP, SundquistWI, FinchJT: Image reconstructions of helical assemblies of the HIV-1 CA protein.Nature407, 409–413 (2000).
  • Stremlau M , PerronM, LeeMet al.: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor.Proc. Natl Acad. Sci. USA103, 5514–5519 (2006).
  • Forshey BM , von SchwedlerU, SundquistWI, AikenC: Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.J. Virol.76, 5667–5677 (2002).
  • Lanman J , LamTT, EmmettMR, MarshallAG, SakalianM, PreveligePEJr: Key interactions in HIV-1 maturation identified by hydrogen–deuterium exchange.Nat. Struct. Mol. Biol.11, 676–677 (2004).
  • Briggs JA , SimonMN, GrossIet al.: The stoichiometry of Gag protein in HIV-1.Nat. Struct. Mol. Biol.11, 672–675 (2004).
  • Zack JA , ArrigoSJ, WeitsmanSR, GoAS, HaislipA, ChenIS: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.Cell61, 213–222 (1990).
  • Bukrinsky MI , StanwickTL, DempseyMP, StevensonM: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.Science254, 423–427 (1991).
  • Tang S , PattersonB, LevyJA: Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation.J. Virol.69, 5659–5665 (1995).
  • Pierson TC , ZhouY, KiefferTL, RuffCT, BuckC, SilicianoRF: Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.J. Virol.76, 8518–8531 (2002).
  • Korin YD , ZackJA: Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells.J. Virol.72, 3161–3168 (1998).
  • Groschel B , BushmanF: Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus.J. Virol.79, 5695–5704 (2005).
  • Auewarakul P , WacharaporninP, SrichatrapimukS, ChutipongtanateS, PuthavathanaP: Uncoating of HIV-1 requires cellular activation.Virology337, 93–101 (2005).
  • Narayan S , YoungJA: Reconstitution of retroviral fusion and uncoating in a cell-free system.Proc. Natl Acad. Sci. USA101, 7721–7726 (2004).
  • Gurer C , CimarelliA, LubanJ: Specific incorporation of heat shock protein 70 family members into primate lentiviral virions.J. Virol.76, 4666–4670 (2002).
  • Gurer C , HoglundA, HoglundS, LubanJ: ATPγS disrupts human immunodeficiency virus type 1 virion core integrity.J. Virol.79, 5557–5567 (2005).
  • DesGroseillers L , JolicoeurP: Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses.J. Virol.48, 685–696 (1983).
  • Stremlau M , OwensCM, PerronMJ, KiesslingM, AutissierP, SodroskiJ: The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys.Nature427, 848–853 (2004).
  • Hatziioannou T , Martin-SerranoJ, ZangT, BieniaszPD: Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.J. Virol.79, 15586–15589 (2005).
  • Wu X , AndersonJL, CampbellEM, JosephAM, HopeTJ: Proteasome inhibitors uncouple rhesus TRIM5α restriction of HIV-1 reverse transcription and infection.Proc. Natl Acad. Sci. USA103, 7465–7470 (2006).
  • Braaten D , FrankeEK, LubanJ: Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.J. Virol.70, 3551–3560 (1996).
  • Luban J , BossoltKL, FrankeEK, KalpanaGV, GoffSP: Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.Cell73, 1067–1078 (1993).
  • Towers GJ , HatziioannouT, CowanS, GoffSP, LubanJ, BieniaszPD: Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.Nat. Med.9, 1138–1143 (2003).
  • Sokolskaja E , SayahDM, LubanJ: Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.J. Virol.78, 12800–12808 (2004).
  • Keckesova Z , YlinenLM, TowersGJ: Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5α antiviral activity.J. Virol.80, 4683–4690 (2006).
  • Jonckheere H , AnneJ, DeClercq E: The HIV-1 reverse transcription (RT) process as target for RT inhibitors.Med. Res. Rev.20, 129–154 (2000).
  • Forshey BM , AikenC: Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex.J. Virol.77, 4409–4414 (2003).
  • Fournier C , CortayJC, CarbonnelleC, EhresmannC, MarquetR, BoulangerP: The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro.Virus Genes25, 255–269 (2002).
  • Mansky LM , TeminHM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.J. Virol.69, 5087–5094 (1995).
  • Chen R , Le RouzicE, KearneyJA, ManskyLM, BenichouS: Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages.J. Biol. Chem.279, 28419–28425 (2004).
  • Le Rouzic E , BenichouS: The Vpr protein from HIV-1, distinct roles along the viral life cycle.RetroVirology2, 11 (2005).
  • Kaiser SM , EmermanM: Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.J. Virol.80, 875–882 (2006).
  • Schrofelbauer B , YuQ, ZeitlinSG, LandauNR: Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.J. Virol.79, 10978–10987 (2005).
  • Zhu K , DobardC, ChowSA: Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.J. Virol.78, 5045–5055 (2004).
  • Sheehy AM , GaddisNC, ChoiJD, MalimMH: Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.Nature418, 646–650 (2002).
  • Bishop KN , HolmesRK, SheehyAM, MalimMH: APOBEC-mediated editing of viral RNA.Science305, 645 (2004).
  • Guo F , CenS, NiuM, SaadatmandJ, KleimanL: The inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during HIV-1 replication.J. Virol. DOI: 10.1128/JVI.01038.06 (2006) (Epub ahead of print).
  • Chiu YL , SorosVB, KreisbergJF, StopakK, YonemotoW, GreeneWC: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.Nature435, 108–114 (2005).
  • Bishop KN , HolmesRK, MalimMH: Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.J. Virol.80, 8450–8458 (2006).
  • Zheng YH , PeterlinBM: Intracellular immunity to HIV-1, newly defined retroviral battles inside infected cells.RetroVirology2, 25 (2005).
  • Mansky LM , PreveralS, SeligL, BenarousR, BenichouS: The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate.J. Virol.74, 7039–7047 (2000).
  • Fassati A , GoffSP: Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.J. Virol.75, 3626–3635 (2001).
  • Li L , OlveraJM, YoderKEet al.: Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.EMBO J.20, 3272–3281 (2001).
  • Cherepanov P , MaertensG, ProostPet al.: HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells.J. Biol. Chem.278, 372–381 (2003).
  • Farnet CM , BushmanFD: HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro.Cell88, 483–492 (1997).
  • Turelli P , DoucasV, CraigEet al.: Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication.Mol. Cell7, 1245–1254 (2001).
  • Chen H , EngelmanA: The barrier-to-autointegration protein is a host factor for HIV type 1 integration.Proc. Natl Acad. Sci. USA95, 15270–15274 (1998).
  • Nermut MV , FassatiA: Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes.J. Virol.77, 8196–8206 (2003).
  • Khiytani DK , DimmockNJ: Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion.J. Gen. Virol.83, 2523–2532 (2002).
  • Feldherr CM , AkinD: Variations in signal-mediated nuclear transport during the cell cycle in BALB/c 3T3 cells.Exp. Cell Res.215, 206–210 (1994).
  • Mattaj IW , EnglmeierL: Nucleocytoplasmic transport: the soluble phase.Annu. Rev. Biochem.67, 265–306 (1998).
  • Lee GE , MurrayJW, WolkoffAW, WilsonDW: Reconstitution of herpes simplex virus microtubule-dependent trafficking in vitro.J. Virol.80, 4264–4275 (2006).
  • Trotman LC , MosbergerN, FornerodM, StidwillRP, GreberUF: Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1.Nat. Cell Biol.3, 1092–1100 (2001).
  • Wisnivesky JP , LeopoldPL, CrystalRG: Specific binding of the adenovirus capsid to the nuclear envelope.Hum. Gene Ther.10, 2187–2195 (1999).
  • Sodeik B : Mechanisms of viral transport in the cytoplasm.Trends Microbiol.8, 465–472 (2000).
  • Taunton J : Actin filament nucleation by endosomes, lysosomes and secretory vesicles.Curr. Opin. Cell Biol.13, 85–91 (2001).
  • Sodeik B : Unchain my heart, baby let me go – the entry and intracellular transport of HIV.J. Cell Biol.159, 393–395 (2002).
  • Tang Y , WinklerU, FreedEOet al.: Cellular motor protein KIF-4 associates with retroviral Gag.J. Virol.73, 10508–10513 (1999).
  • Petit C , GironML, Tobaly-TapieroJet al.: Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8.J. Cell Sci.116, 3433–3442 (2003).
  • Garcia-Mata R , GaoYS, SztulE: Hassles with taking out the garbage: aggravating aggresomes.Traffic3, 388–396 (2002).
  • Wei BL , DentonPW, O‘NeillE, LuoT, FosterJL, GarciaJV: Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection.J. Virol.9, 5705–5712 (2005).
  • Schwartz O , MarechalV, FriguetB, Arenzana-SeisdedosF, HeardJM: Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.J. Virol.72, 3845–3850 (1998).
  • Campbell EM , HopeTJ: Gene therapy progress and prospects: viral trafficking during infection.Gene Ther.12, 1353–1359 (2005).
  • Bukrinsky M : A hard way to the nucleus.Mol. Med.10, 1–5 (2004).
  • Yamashita M , EmermanM: The cell cycle independence of HIV infections is not determined by known karyophilic viral elements.PLoS Pathog.1, E18 (2006).
  • Zennou V , PetitC, GuetardD, NerhbassU, MontagnierL, CharneauP: HIV-1 genome nuclear import is mediated by a central DNA flap.Cell101, 173–185 (2000).
  • Dvorin JD , BellP, MaulGG, YamashitaM, EmermanM, MalimMH: Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import.J. Virol.76, 12087–12096 (2002).
  • Arhel NJ , Souquere-BesseS, CharneauP: Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels.RetroVirology3, 38 (2006).
  • Jacque JM , StevensonM: The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity.Nature441, 641–645 (2006).
  • Beitzel B , BushmanF: Construction and analysis of cells lacking the HMGA gene family.Nucleic Acids Res.31, 5025–5032 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.